SEC Filing Details
Document Details
Form
Filing Date
Feb 5, 2026
Document Date
Jan 20, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Lexeo Therapeutics
Issuer
LEXEO THERAPEUTICS, INC.
Filer
BHALLA NARINDER PAL
Contact Us
-
Investor Inquiries -
Media Inquiries
